Zeng Xinxin, Jinlong Gong, Huang Huaiyin, Xianbo Shen, Hongying Tang. "Donafenib combined with anti–PD-1 antibody as adjuvant therapy for patients with hepatocellular carcinoma at high risk of recurrence after resection.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16266